MD+DI

Breaking down the latest news in medical technology and healthcare.

[MD+DI @MDDIonline]

Medtronic's CEO said they're "going on the offense" with acquisitions — and they're not bluffing 💰
From AI-powered surgical robots to $738M deals, here's how the medtech giant is shopping its way to growth: https://t.co/cBJE3wPIbG

[MD+DI @MDDIonline]

InMode's CEO just made a $1.2B bid to take the company private — but plot twist: this is the SECOND takeover attempt in months
What's really going on behind the scenes at the aesthetic device maker? https://t.co/S96kAFayhX

[MD+DI @MDDIonline]

Whoop said "we're not removing it" when everyone told them to back down, and the FDA just blinked first 👀
How one wearable stood its ground and won a year-long regulatory showdown over blood pressure monitoring: https://t.co/okykD9vxeJ

[MD+DI @MDDIonline]

@Medtronic 's CEO said they're "going on the offense" with acquisitions — and they're not bluffing 💰
From AI-powered surgical robots to $738M deals, here's how the medtech giant is shopping its way to growth: https://t.co/cBJE3wQg1e

[MD+DI @MDDIonline]

@WHOOP said "we're not removing it" when everyone told them to back down, and the FDA just blinked first 👀
How one wearable stood its ground and won a year-long regulatory showdown over blood pressure monitoring: https://t.co/okykD9vxeJ

[MD+DI @MDDIonline]

@senseonics + @Welldoc = a powerful CGM upgrade.
The duo is teaming up to enhance the Eversense 365 app and deliver smarter diabetes management: https://t.co/1xstLkBekS

[MD+DI @MDDIonline]

When your distribution center burns down but your supply chain doesn't skip a beat 🔥💪
@Medline 's crisis response playbook is a masterclass in operational resilience. Here's how they kept hospitals stocked when disaster struck: https://t.co/zzEIaIyfMc

[MD+DI @MDDIonline]

@penumbrainc just scored FDA clearance and CE Mark for THUNDERBOLT—the first computer-assisted vacuum thrombectomy device for stroke. The move comes ahead of an impending @bostonsci acquisition 🧠⚡https://t.co/GxaTMFXvdk

[MD+DI @MDDIonline]

Your skin changes as you age—and that's a problem for continuous glucose monitors. Here's why aging skin is throwing off CGM accuracy. 📉 https://t.co/zkDNmchtR5

[MD+DI @MDDIonline]

Gender discrimination lawsuits are piling up in medtech. From pay gaps to hostile work environments, the industry has a serious problem. 🚨https://t.co/kGkLvYG97z

[MD+DI @MDDIonline]

A new compression device is targeting POTS symptoms—and it's aiming for a 2027 launch. Could be a game-changer for millions living with the condition. 👇https://t.co/exzQvvMbet

[MD+DI @MDDIonline]

Karl Storz is cutting 108 jobs from its Asensus Surgical subsidiary. Another round of layoffs hitting surgical robotics. https://t.co/Z2oO9vCM1A

[MD+DI @MDDIonline]

That $1,700 "smart" bassinet parents are obsessed with? FDA just issued a warning letter. Unapproved sizes, safety risks, and mold complaints. https://t.co/VKGbLowbrl

[MD+DI @MDDIonline]

Healthcare can detect threats—but can't fix them fast enough ⚡
Attackers exploit vulnerabilities in hours. Organizations take weeks to remediate.
Speed isn't a nice-to-have. It's the difference between stopping a breach and becoming the next headline. https://t.co/NFpJ5QDKHd

[MD+DI @MDDIonline]

Crowdfunding for medtech? 💰
Wefunder is opening doors for startups to raise capital from everyday investors—here's your strategy guide to making it work. https://t.co/GXrHFYbGQn

[MD+DI @MDDIonline]

Novocure's Trident trial misses primary endpoint in metastatic pancreatic cancer 📉
Tumor Treating Fields (TTFields) + chemotherapy did not show statistically significant improvement in overall survival vs. chemo alone.
A setback for the company's expansion beyond glioblastoma. https://t.co/eUmCQFVi7L

[MD+DI @MDDIonline]

@ZeusTubing just launched XpanCore—a heat-activated mandrel that expands on demand to solve one of catheter manufacturing's biggest headaches 🔥
The tech simplifies laser-cut hypotube assembly, cutting build time, reducing scrap, and improving liner placement for next-gen interventional devices: https://t.co/ojl4xCTsNm

[MD+DI @MDDIonline]

⚠️ FDA Alert: Breast biopsy needle shortage expected to last through March 2027
The agency is urging healthcare providers to conserve supplies, prioritize high-risk patients, and consider alternative biopsy methods where clinically appropriate.
A critical supply chain issue affecting breast cancer diagnostics nationwide. https://t.co/PLatqVUS9V

[MD+DI @MDDIonline]

Stanford spinout Adaptyx unveiled the first continuous cortisol monitor at #ADA2026 🧬
Using DNA-based molecular switches, the wearable sensor tracks the "master stress hormone" for multiple days—detecting concentrations 1 million times lower than glucose.
A breakthrough for diabetes, hypertension & beyond. @AdaptyxBiosci
https://t.co/B7gRWWiW70